NYSE$KVUE

Kenvue Inc · Q3 2025 earnings

Q3 2025 earnings · · Before market open · Investor relations

Briefing

Kenvue reported Q3 2025 net sales of $3.76B with net income of $398M.

Net sales were $3.76 billion for the quarter ended September 28, 2025, with net income of $398 million. Self-care and skin health brands continue to anchor volume while the company executes productivity and portfolio actions.

  • Q3 net sales $3.76B.
  • Net income $398M.
  • Self-care and skin health portfolio performance key.
  • Productivity and separation-related costs affect margins.

Headline financials

Total Revenue

$3.76B

Previous: $3.91B-3.8%
EPS (adj)

$0.28

Previous: $0.20+40.0%
Gross Profit Margin

59.1%

Previous: 58.5%+1.0%
Adjusted Gross Margin

61.2%

Previous: 60.7%+0.8%
Operating Margin

16.7%

Previous: 16.8%-0.6%
Adjusted Operating Margin

21.5%

Previous: 22.1%-2.7%
Effective Tax Rate

24.3%

Previous: 33.6%-27.7%
Adjusted Tax Rate

24.0%

Previous: 28.9%-17.0%
R&D Expenses

$94M

No prior period
Organic Sales Growth

-4.4%

No prior period
Organic Volume Growth

-4.0%

No prior period
Organic Price/Mix Growth

-0.4%

No prior period
Capital Expenditures

-$365M

Previous: -$302M-20.9%
Free Cash Flow

$33M

Previous: $81M-59.3%
Net Income

$398M

Previous: $383M+3.9%
Operating Income

$629M

Previous: $654M-3.8%
Gross Profit

$2.23B

Previous: $2.28B-2.5%
Cash & Equivalents

$1.14B

Previous: $1.06B+7.8%
Total Assets

$27.2B

Previous: $26.9B+1.2%

Revenue & EPS history

Kenvue · Revenue · Quarterly

$3.76B

Q3 2025-3.8%vs Q3 2024
Beat estimate in 7 of 12 quarters(58%)
ActualEstimate

Revenue by segment

Kenvue · $3.92B total across 3 segments · Q3 2023

  • Self Care
    $1.61B+6.4%
  • Essential Health
    $1.18B+3.0%
  • Skin Health & Beauty
    $1.12B-0.4%

Forward guidance

The filing discusses Kenvue's outlook, capital deployment, and key risks without relying solely on numeric EPS guidance.

Tailwinds

  • Kenvue cites execution on strategic priorities in the filing.
  • Balance sheet and liquidity support continued operations.

Headwinds

  • Macro, competitive, and cost pressures may affect margins.
  • Segment mix and one-time items can affect comparability.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 13 quarterly earnings reports · overlaid with Q3 2025

Historical avgQ3 2025

+2.0%

Avg return

Earnings day

+3.1%

Avg return

5 days after

+2.8%

Avg return

30 days after

57%

8 / 14 earnings

Positive

+15.7%

Q3 2025

Best reaction

-7.7%

Q3 2023

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+2.0%-1.2%+0.2%
Q4 2025+0.9%+2.9%-5.5%
Q3 2025+15.7%+17.5%+18.1%
Q2 2025+1.5%+2.1%-13.2%
Q1 2025+4.3%+2.4%-6.0%
Q4 2024-4.5%+0.8%+12.9%
Q3 2024+5.2%+5.1%+1.5%
Q2 2024+13.4%+15.6%+23.7%
Q1 2024+7.2%+7.7%-2.4%
Q4 2022-0.2%+3.1%+12.9%
Q4 2023-5.8%-6.2%-2.4%
Q3 2023-7.7%-5.7%+2.6%
Q2 2023-4.0%+0.5%-8.5%
Q1 2023-0.5%-0.8%+4.5%
Q3 2022
Q2 2022
Q1 2022
Q4 2021

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro